SCHEMBL20829809

SCHEMBL20829809

IC1c2ccccc2-c2ncoc2-c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22261561 0.83 KDM4E (0.45) MAPK14
SCHEMBL22413469 0.79 MAPK14 (0.33) MAPK14
SCHEMBL20829701 0.74 ALDH1A1 (0.47)
SCHEMBL20829599 0.72 GPR3 (0.44)
SCHEMBL7930812 0.70 GPR3 (0.46)
SCHEMBL31435352 0.69 MAPK14 (0.56) MAPK14
SCHEMBL20829553 0.69 PTPRC (0.46)
SCHEMBL2294786 0.69 CYP1A2 (0.39) MAPK14
SCHEMBL20829556 0.69 PTPRC (0.46)
SCHEMBL2292117 0.68 NPY5R (0.41) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686201-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2020-07-29 EP disclosed
WO-2019052565-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF 广东东阳光药业有限公司 2019-03-21 WO disclosed